NCT03781895View on ClinicalTrials.gov

Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

February 1, 2018

Study Completion Date

February 1, 2018

Conditions

Stable COPD Patients

Interventions

DRUG

Cholecalciferol

"• Cholecalciferol (40,000IU),~,Microcrystalline Cellulose (58.1 gm), Butylated Hydroxy Toluene ( 0.2mg),Magnesium Stearate (3mg),Gelatin Capsule Shell (1mg)"

Trial Locations (1)

1213

Samia Hassan, Dhaka

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT03781895 - Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients | Biotech Hunter | Biotech Hunter